Net debt/EBITDA společnosti Apellis Pharmaceuticals Inc
Jaká je hodnota metriky Net debt/EBITDA společnosti Apellis Pharmaceuticals Inc?
Hodnota metriky Net debt/EBITDA společnosti Apellis Pharmaceuticals Inc je 5.26
Jaká je definice metriky Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Apellis Pharmaceuticals Inc
Čemu se věnuje společnost Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Firmy s metrikou net debt/ebitda podobnou společnosti Apellis Pharmaceuticals Inc
- Hodnota metriky Net debt/EBITDA společnosti Keller Plc je 5.24
- Hodnota metriky Net debt/EBITDA společnosti Noxopharm je 5.24
- Hodnota metriky Net debt/EBITDA společnosti Enel Americas SA je 5.25
- Hodnota metriky Net debt/EBITDA společnosti Alaska Air je 5.25
- Hodnota metriky Net debt/EBITDA společnosti Alturas Minerals je 5.25
- Hodnota metriky Net debt/EBITDA společnosti Live Nation Entertainment Inc je 5.26
- Hodnota metriky Net debt/EBITDA společnosti Apellis Pharmaceuticals Inc je 5.26
- Hodnota metriky Net debt/EBITDA společnosti Sunrise Realty Trust je 5.26
- Hodnota metriky Net debt/EBITDA společnosti Polished.com Inc je 5.27
- Hodnota metriky Net debt/EBITDA společnosti Valneva SE je 5.27
- Hodnota metriky Net debt/EBITDA společnosti Valneva SE je 5.27
- Hodnota metriky Net debt/EBITDA společnosti Valneva SE je 5.27
- Hodnota metriky Net debt/EBITDA společnosti Solocal S.A je 5.27